<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Ciarloni, Laura</dc:creator>
  <dc:creator>Hosseinian, Sahar</dc:creator>
  <dc:creator>Monnier-Benoit, Sylvain</dc:creator>
  <dc:creator>Imaizumi, Natsuko</dc:creator>
  <dc:creator>Dorta, Gian</dc:creator>
  <dc:creator>Rüegg, Curzio</dc:creator>
  <dc:date>2015-04-13</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Colorectal cancer (CRC) is the second leading cause of cancer-related death in  developed countries. Early detection of CRC leads to decreased CRC mortality. A  blood-based CRC screening test is highly desirable due to limited invasiveness and  high acceptance rate among patients compared to currently used fecal occult blood  testing and colonoscopy. Here we describe the discovery and validation of a 29-gene  panel in peripheral blood mononuclear cells (PBMC) for the detection of CRC and  adenomatous polyps (AP). Blood samples were prospectively collected from a  multicenter, case-control clinical study. First, we profiled 93 samples with 667  candidate and 3 reference genes by high throughput real-time PCR (OpenArray  system). After analysis, 160 genes were retained and tested again on 51 additional  samples. Low expressed and unstable genes were discarded resulting in a final  dataset of 144 samples profiled with 140 genes. To define which genes, alone or in  combinations had the highest potential to discriminate AP and/or CRC from controls,  data were analyzed by a combination of univariate and multivariate methods. A list of  29 potentially discriminant genes was compiled and evaluated for its predictive  accuracy by penalized logistic regression and bootstrap. This method discriminated  AP &gt;1cm and CRC from controls with a sensitivity of 59% and 75%, respectively, with  91% specificity. The behavior of the 29-gene panel was validated with a LightCycler  480 real-time PCR platform, commonly adopted by clinical laboratories. In this work  we identified a 29-gene panel expressed in PBMC that can be used for developing a  novel minimally-invasive test for accurate detection of AP and CRC using a standard  real-time PCR platform.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/304192</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/304192/files/rue_dtg.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/304192/files/rue_dtg_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0123904</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>PLoS ONE. - 2015, vol. 10, no. 4, p. e0123904</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
